147 related articles for article (PubMed ID: 31838249)
1. The prognostic value of cyclin D1 expression in the survival of cancer patients: A meta-analysis.
Moradi Binabaj M; Bahrami A; Khazaei M; Ryzhikov M; Ferns GA; Avan A; Mahdi Hassanian S
Gene; 2020 Feb; 728():144283. PubMed ID: 31838249
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis.
Jiang Y; Zhang C; Lu L; Wang X; Liu H; Jiang Y; Hong L; Chen Y; Huang H; Guo D
Technol Cancer Res Treat; 2022; 21():15330338211065252. PubMed ID: 35098809
[No Abstract] [Full Text] [Related]
3. The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis.
Ren B; Li W; Yang Y; Wu S
World J Surg Oncol; 2014 Mar; 12():55. PubMed ID: 24602161
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of cyclin D1 amplification in patients with breast cancer: a meta-analysis.
He Q; Wu J; Liu XL; Ma YH; Wu XT; Wang WY; An HX
J BUON; 2017; 22(5):1209-1216. PubMed ID: 29135104
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies.
Li Y; Wei J; Xu C; Zhao Z; You T
PLoS One; 2014; 9(4):e94508. PubMed ID: 24728073
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Cyclin D1 Expression in Renal Cell Carcinoma: a Systematic Review and Meta-analysis.
Li Z; Liu J; Zhang X; Fang L; Zhang C; Zhang Z; Yan L; Tang Y; Fan Y
Pathol Oncol Res; 2020 Jul; 26(3):1401-1409. PubMed ID: 31748879
[TBL] [Abstract][Full Text] [Related]
7. Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer.
Villegas SL; Darb-Esfahani S; von Minckwitz G; Huober J; Weber K; Marmé F; Furlanetto J; Schem C; Pfitzner BM; Lederer B; Engels K; Kümmel S; Müller V; Mehta K; Denkert C; Loibl S
Breast Cancer Res Treat; 2018 Feb; 168(1):179-187. PubMed ID: 29177689
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ruiz-Ávila I; Ayén Á; Gil-Montoya JA
Oral Oncol; 2018 Aug; 83():96-106. PubMed ID: 30098785
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma.
Gioacchini FM; Alicandri-Ciufelli M; Kaleci S; Magliulo G; Presutti L; Re M
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):801-9. PubMed ID: 25516222
[TBL] [Abstract][Full Text] [Related]
10. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and Predictive Value of
Jeffreys SA; Becker TM; Khan S; Soon P; Neubauer H; de Souza P; Powter B
Front Endocrinol (Lausanne); 2022; 13():895729. PubMed ID: 35784572
[TBL] [Abstract][Full Text] [Related]
13. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta-analysis.
Ding ZY; Li R; Zhang QJ; Wang Y; Jiang Y; Meng QY; Xi QL; Wu GH
Cancer Med; 2019 Jun; 8(6):2717-2729. PubMed ID: 30950241
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.
Sun X; Zhangyuan G; Shi L; Wang Y; Sun B; Ding Q
Medicine (Baltimore); 2017 May; 96(19):e6860. PubMed ID: 28489780
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC).
Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E
J Cancer Res Clin Oncol; 2005 Jul; 131(7):479-85. PubMed ID: 15809880
[TBL] [Abstract][Full Text] [Related]
18. Association of
Yan H; Jiang F; Yang J
Genet Res (Camb); 2022; 2022():5338956. PubMed ID: 36072013
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis.
Mao Q; Chen Z; Wang K; Xu R; Lu H; He X
Cell Physiol Biochem; 2018; 50(1):66-78. PubMed ID: 30278466
[TBL] [Abstract][Full Text] [Related]
20. The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis.
Xu XL; Chen SZ; Chen W; Zheng WH; Xia XH; Yang HJ; Li B; Mao WM
Breast Cancer Res Treat; 2013 Jun; 139(2):329-39. PubMed ID: 23670132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
